FGFR3 and carcinoma: Interestingly, there was no difference between pure squamous cell carcinoma and mixed carcinomas with squamous differentiation, and validation by a subgroup analysis of the “squamous-like” TCGA subgroup showing 4.9% of FGFR3 mutations corroborated our results.